Canada · Delayed Price · Currency is CAD Alzai Health Statistics
Total Valuation
Alzai Health has a market cap or net worth of CAD 24.06 million. The enterprise value is 23.84 million.
| Market Cap | 24.06M |
| Enterprise Value | 23.84M |
Important Dates
The next estimated earnings date is Thursday, November 26, 2026.
| Earnings Date | Nov 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Alzai Health has 64.15 million shares outstanding.
| Current Share Class | 64.15M |
| Shares Outstanding | 64.15M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +3.22% |
| Owned by Insiders (%) | 13.87% |
| Owned by Institutions (%) | n/a |
| Float | 55.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 889.65 |
| PB Ratio | -18.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.33
| Current Ratio | 0.33 |
| Quick Ratio | 0.30 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.32 |
| Interest Coverage | -63.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -469.01% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 473.80% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.55 |
| Average Volume (20 Days) | 19,065 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Alzai Health had revenue of CAD 27,039 and -3.68 million in losses. Loss per share was -0.07.
| Revenue | 27,039 |
| Gross Profit | -387,937 |
| Operating Income | -3.62M |
| Pretax Income | -3.68M |
| Net Income | -3.68M |
| EBITDA | -3.61M |
| EBIT | -3.62M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 268,074 in cash and 833,889 in debt, with a net cash position of -565,815 or -0.01 per share.
| Cash & Cash Equivalents | 268,074 |
| Total Debt | 833,889 |
| Net Cash | -565,815 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -1.32M |
| Book Value Per Share | -0.02 |
| Working Capital | -870,610 |
Cash Flow
In the last 12 months, operating cash flow was -2.59 million and capital expenditures -18,635, giving a free cash flow of -2.61 million.
| Operating Cash Flow | -2.59M |
| Capital Expenditures | -18,635 |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -2.61M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | -13,405.82% |
| Pretax Margin | -13,593.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Alzai Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -15.28% |
| FCF Yield | -10.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |